ImmunoPrecise Antibodies Ltd.

TSXV:IPA Rapporto sulle azioni

Cap. di mercato: CA$162.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

ImmunoPrecise Antibodies Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Jennifer Bath

Amministratore delegato

CA$1.9m

Compenso totale

Percentuale dello stipendio del CEO34.9%
Mandato del CEO4.8yrs
Proprietà del CEO0.4%
Durata media del management1.3yrs
Durata media del Consiglio di amministrazione4.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Oct 20
We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Dec 23
Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Nov 25
Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Jennifer Bath rispetto agli utili di ImmunoPrecise Antibodies?
DataCompenso totaleStipendioGuadagni aziendali
Jul 31 2022n/an/a

-CA$23m

Apr 30 2022CA$2mCA$649k

-CA$17m

Jan 31 2022n/an/a

-CA$17m

Oct 31 2021n/an/a

-CA$15m

Jul 31 2021n/an/a

-CA$10m

Apr 30 2021CA$2mCA$503k

-CA$7m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$3m

Jul 31 2020n/an/a

-CA$3m

Apr 30 2020CA$673kCA$488k

-CA$5m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$8m

Jul 31 2019n/an/a

-CA$9m

Apr 30 2019CA$1mCA$505k

-CA$8m

Jan 31 2019n/an/a

-CA$6m

Oct 31 2018n/an/a

-CA$6m

Jul 31 2018n/an/a

-CA$5m

Apr 30 2018CA$65kCA$65k

-CA$5m

Compensazione vs Mercato: Jennifer's total compensation ($USD1.39M) is above average for companies of similar size in the Canadian market ($USD178.89K).

Compensazione vs guadagni: Jennifer's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Jennifer Bath

4.8yrs

Mandato

CA$1,856,482

Compensazione

Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of ImmunoPrecise Antibodies Ltd. since February 21, 2018.Dr. Bath served as the Global Director of Client Relations at Ald...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Jennifer Bath
CEO, President & Non-Independent Director4.8yrsCA$1.86m0.44%
CA$ 707.3k
Brad McConn
Chief Financial Officerless than a yearCA$432.71k0.032%
CA$ 52.0k
Ilse Roodink
Chief Scientific Officer1.3yrsCA$514.16k0.013%
CA$ 21.7k
David Orton
Chief Operating Officer5.7yrsNessun datoNessun dato
Carla Dahl
Vice President of Marketing1.3yrsNessun dato0.040%
CA$ 65.0k
Barry Duplantis
Vice President of Client Relationsno dataNessun dato0.0048%
CA$ 7.8k

1.3yrs

Durata media

Gestione esperta: IPA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Jennifer Bath
CEO, President & Non-Independent Director4.5yrsCA$1.86m0.44%
CA$ 707.3k
James Kuo
Independent Chairman of the Board5.9yrsCA$130.84k0.10%
CA$ 162.5k
Gregory Smith
Independent Director6.2yrsCA$95.66k0.17%
CA$ 282.7k
Guy Champagne
Member of Advisory Board4.3yrsCA$55.00kNessun dato
Robert Burke
Independent Director4.9yrsCA$87.99k0.12%
CA$ 201.5k
Dion Neame
Member of Strategic Advisory Board1.5yrsNessun datoNessun dato
Anna Pettersson
Independent Directorless than a yearCA$75.55kNessun dato

4.5yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: IPA's board of directors are considered experienced (4.5 years average tenure).